Veuillez utiliser cette adresse pour citer ce document :
https://hdl.handle.net/20.500.12177/7933
Titre: | Chemical and pharmacological studies of two medicinal plants: Tabernaemontana contorta stapf and Tabernaemontana inconspicua stapf (apocynaceae) |
Auteur(s): | Foudjo Melacheu, Gertrude Laura |
Directeur(s): | Wandji, Jean Seguin, Elisabeth |
Mots-clés: | Apocynaceae Tabernaemontana contorta Secondary metabolites Anticancer effect. |
Date de publication: | 2021 |
Editeur: | Université de Yaoundé I |
Résumé: | This work describes the isolation and structure elucidation of secondary metabolites from the fruits and stem-bark of Tabernaemontana contorta and stem Tabernaemontana inconspicua, as well as the evaluation of the anti-inflammatory and cytotoxicity potencies of some isolated compounds. In this study, a total of 28 compounds were isolated using chromatographic techniques and characterized using spectroscopic methods. These compounds were classified as: 9 alkaloids with 3 new derivatives, 8 triterpeniods with 1 new derivative, 1 monoterpene, 7 lipids with 1 new cerebroside and 3 steriods. Two of the new indole alkaloids (apparicine-21-one and 5,6-dioxo-11-methoxyvoacangine) were tested for their anti-inflammatory activity but no significant activity was observed. The anticancer potency of eight of these compounds was carried on human breast cancer cells and 5,6-dioxo-11-hydroxy voacangine showed a significant activity. This compound inhibited the cell growth in both a concentration and time-dependent manner, and it therefore suggests that this compound be used as a chemotherapeutic agent since it was found to be more effective over time exposure. |
Pagination / Nombre de pages: | 199p. |
URI/URL: | https://hdl.handle.net/20.500.12177/7933 |
Collection(s) : | Thèses soutenues |
Fichier(s) constituant ce document :
Fichier | Description | Taille | Format | |
---|---|---|---|---|
FS_These_BC21_0126.pdf | 8.71 MB | Adobe PDF | Voir/Ouvrir |
Tous les documents du DICAMES sont protégés par copyright, avec tous droits réservés.